Bivatuzumab BIWA 4: A New Treatment Candidate Bivatuzumab BIWA 4 shows a novel medicinal agent for managing specific tumors. This molecule selectively binds a critical protein participating in tumor growth and progression. Early research findings suggest possibility for significant benefit and a acceptable profile in administered separately or in